Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma

Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced acute and late toxicity as compared with inte...

Full description

Bibliographic Details
Main Authors: William M. Mendenhall, MD, Jonathan J. Beitler, MD, MBA, Nabil F. Saba, MD, FACP, Ashok R. Shaha, MD, FACS, Sandra Nuyts, MD, PhD, Primož Strojan, MD, Heleen Bollen, MD, Oded Cohen, MD, Robert Smee, MD, Sweet Ping Ng, MD, Avraham Eisbruch, MD, Wai Tong Ng, MD, Jessica M. Kirwan, MA, Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP
Format: Article
Language:English
Published: Particle Therapy Co-operative Group 2023-04-01
Series:International Journal of Particle Therapy
Subjects:
Online Access:https://theijpt.org/doi/pdf/10.14338/IJPT-22-00030.1
_version_ 1797831445424635904
author William M. Mendenhall, MD
Jonathan J. Beitler, MD, MBA
Nabil F. Saba, MD, FACP
Ashok R. Shaha, MD, FACS
Sandra Nuyts, MD, PhD
Primož Strojan, MD
Heleen Bollen, MD
Oded Cohen, MD
Robert Smee, MD
Sweet Ping Ng, MD
Avraham Eisbruch, MD
Wai Tong Ng, MD
Jessica M. Kirwan, MA
Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP
author_facet William M. Mendenhall, MD
Jonathan J. Beitler, MD, MBA
Nabil F. Saba, MD, FACP
Ashok R. Shaha, MD, FACS
Sandra Nuyts, MD, PhD
Primož Strojan, MD
Heleen Bollen, MD
Oded Cohen, MD
Robert Smee, MD
Sweet Ping Ng, MD
Avraham Eisbruch, MD
Wai Tong Ng, MD
Jessica M. Kirwan, MA
Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP
author_sort William M. Mendenhall, MD
collection DOAJ
description Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced acute and late toxicity as compared with intensity-modulated radiation therapy (IMRT). The extent of the reduced toxicity, which may be modest, depends on the endpoint and technical factors such as pencil beam versus passive scattered PBT and adaptive replanning. The disease control rates after PBT are likely similar to those after IMRT. Conclusion: Proton beam therapy is an attractive option to treat patients with OPSCC. Whether it becomes widely available depends on access.
first_indexed 2024-04-09T13:52:59Z
format Article
id doaj.art-f38473e8146f48049b2d5d531735ec05
institution Directory Open Access Journal
issn 2331-5180
language English
last_indexed 2024-04-09T13:52:59Z
publishDate 2023-04-01
publisher Particle Therapy Co-operative Group
record_format Article
series International Journal of Particle Therapy
spelling doaj.art-f38473e8146f48049b2d5d531735ec052023-05-08T13:32:18ZengParticle Therapy Co-operative GroupInternational Journal of Particle Therapy2331-51802023-04-019424325210.14338/IJPT-22-00030.1i2331-5180-9-4-243Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell CarcinomaWilliam M. Mendenhall, MD0Jonathan J. Beitler, MD, MBA1Nabil F. Saba, MD, FACP2Ashok R. Shaha, MD, FACS3Sandra Nuyts, MD, PhD4Primož Strojan, MD5Heleen Bollen, MD6Oded Cohen, MD7Robert Smee, MD8Sweet Ping Ng, MD9Avraham Eisbruch, MD10Wai Tong Ng, MD11Jessica M. Kirwan, MA12Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP131 Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA2 Harold Alfonds Center for Cancer Care, Maine General Hospital, Augusta, ME, USA3 Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA4 Department of Head and Neck Surgery and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA5 Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven -University of Leuven, Leuven, Belgium7 Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia5 Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven -University of Leuven, Leuven, Belgium8 Department of Otolaryngology - Head and Neck Surgery and Oncology, Soroka Medical Center, Tel Aviv, Affiliated with Ben Gurion University of the Negev, Beer Sheva, Israel9 Department of Radiation Oncology, The Prince of Wales Cancer Centre, Sydney, NSW, Australia10 Department of Radiation Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Australia11 Department of Radiation Oncology, University of Michigan Medicine, Ann Arbor, Michigan, USA12 Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China1 Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA13 Coordinator of the International Head and Neck Scientific Group, Padua, ItalyPurpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced acute and late toxicity as compared with intensity-modulated radiation therapy (IMRT). The extent of the reduced toxicity, which may be modest, depends on the endpoint and technical factors such as pencil beam versus passive scattered PBT and adaptive replanning. The disease control rates after PBT are likely similar to those after IMRT. Conclusion: Proton beam therapy is an attractive option to treat patients with OPSCC. Whether it becomes widely available depends on access.https://theijpt.org/doi/pdf/10.14338/IJPT-22-00030.1particle therapyhead and neck canceroropharynxcancer outcomes
spellingShingle William M. Mendenhall, MD
Jonathan J. Beitler, MD, MBA
Nabil F. Saba, MD, FACP
Ashok R. Shaha, MD, FACS
Sandra Nuyts, MD, PhD
Primož Strojan, MD
Heleen Bollen, MD
Oded Cohen, MD
Robert Smee, MD
Sweet Ping Ng, MD
Avraham Eisbruch, MD
Wai Tong Ng, MD
Jessica M. Kirwan, MA
Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP
Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
International Journal of Particle Therapy
particle therapy
head and neck cancer
oropharynx
cancer outcomes
title Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
title_full Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
title_fullStr Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
title_full_unstemmed Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
title_short Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
title_sort proton beam radiation therapy for oropharyngeal squamous cell carcinoma
topic particle therapy
head and neck cancer
oropharynx
cancer outcomes
url https://theijpt.org/doi/pdf/10.14338/IJPT-22-00030.1
work_keys_str_mv AT williammmendenhallmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT jonathanjbeitlermdmba protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT nabilfsabamdfacp protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT ashokrshahamdfacs protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT sandranuytsmdphd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT primozstrojanmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT heleenbollenmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT odedcohenmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT robertsmeemd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT sweetpingngmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT avrahameisbruchmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT waitongngmd protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT jessicamkirwanma protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma
AT alfioferlitomddlodpathfrcsedadhominemfrcsengglasgiradeundemfdsrcsadeundemfacsfhkcorlfrcpathfascpifcap protonbeamradiationtherapyfororopharyngealsquamouscellcarcinoma